CytoDyn Appoints Lauren Wilcoxen as Chief Operating Officer
CytoDyn (CYDY) has announced the appointment of Lauren Wilcoxen, Ph.D., to the role of Chief Operating Officer and Head of Regulatory Affairs. The appointment is scheduled to take effect on November 20, 2026. Dr. Wilcoxen joins CytoDyn from Xilio Therapeutics, where she most recently served as Senior Vice President of Regulatory Affairs. Her transition into this leadership role is expected to oversee the company's operational and regulatory strategies moving forward.
Coverage
- Ethos Support Appoints Nathanael Robbins as Chief Operating Officer
- CytoDyn Appoints Lauren Wilcoxen as Chief Operating Officer
- SIRIUS XM HOLDINGS INC. - 8-K Filing
- Albertsons Companies, Inc. - 8-K Filing
- CMC Announces CFO Succession Plan with Appointment of Kenji Hashimoto
- Erie Indemnity Announces Retirement of CEO Timothy NeCastro